|
Letters, Testimony, Comments
|
- Revision to the Time for Filing of a Biological Deposit and the Date of Availability of a Biological Deposit April 21, 2008
BIO's comments to the United States Patent & Trademark Office regardingthe Proposed Rule Changes Concerning
Biological Deposits
Read the statement (170 KB PDF)
- Stifling or Stimulating - The Role of Gene Patents in Research and Genetic Testing (October 30, 2007)
Bio's statement to the Judiciary Subcommittee on Courts, the Internet and Intellectual Property
Read the statement (795 KB PDF)
- BIO's Statement to the Senate Committee on the Judiciary on the Role of Federally-Funded University Research in the Patent System (October 24, 2007)
BIO's statement on the Senate Committee on the Judiciary
Read the statement (438 KB PDF)
- BIO's Comments to the US Patent and Trademark Office on Proposed Rule Changes Concerning Claims Containing Alternative Language (October 9, 2007)
BIO's comments to the Patent and Trademark Office
Read the comments (3.1 MB PDF)
- Patent Law Harmonization (June 22, 2007)
BIO Letter to the Patent and Trademark Office.
Read the letter (525 KB PDF)
- Patent Reform: The Future of American Innovation (June 6, 2007)
Written Testimony of Kathryn L. Biberstein, Senior Vice President General Counsel and Secretary, Chief Compliance Officer, Alkermes, Inc. before the Senate Committee on the Judiciary.
Read the testimony
Read the press release
- H.R. 1908, the Patent Reform Act of 2007 (April 26, 2007)
BIOís statement to the House Judiciary Subcommittee on Courts, the Internet and Intellectual Property
Read the statement (44 KB PDF)
- Identification of Countries involving the Special 301 provisions (February, 2007)
Letter to the Office of the U.S. Trade Representative
Read the letter (664 KB PDF)
- Convention on Biology Diversity and Patent Disclosure Requirements (October 23, 2006)
Letter from BIO, EuropaBIO, BIOTECanada and CropLive International to the TRIPS Council, World Trade Organization
Read the letter (76 KB PDF)
- USPTO's proposed 5-year Strategic Plan (October 6, 2006)
BIO's written comments
Read the comments (490 KB PDF)
- Comments to the USPTO on the proposed rule changes to Information Disclosure Statements (September 9, 2006)
Read the letter (812 KB PDF)
- Letter to the State Intellectual Property Office of the Peoples' Republic of China (August 28, 2006)
Comments on the draft amendments to the Chinese patent laws
Read the letter (361 KB PDF)
- Comments from BIO in response to the proposed California IP regulation for non-profit organizations (384 KB PDF) (June 16, 2006)
- BIO letter in support of H.R. 5418 (June 14, 2006)
To establish a pilot program for educating district court judges on patent related issues.
Read the letter (384 KB PDF)
- Letter opposing proposed PTO changes to patent rules that would limit continuations and examined claims (829 KB PDF) (May 2, 2006)
- Letter opposing amendments to the TRIPs agreement to the Honorable Robert Portman, U.S. Trade Representative (140 KB PDF) (Dec. 6, 2005)
- BIO Response to PTO's Green Paper (60 KB PDF) (Sep 14, 2005)
- BIO Comments on OECD Guidelines (03/11/2005; 337 KB PDF)
- BIO Comments on NAS Report (PDF) (10/26/2004)
- Letter regarding "Patent Quality Improvement: Post-Grant Opposition" (July 8, 2004) to Committee on the Judiciary, Subcommittee on Courts, the Internet and Intellectual Property The Honorable Lamar Smith, Chairman and The Honarable Howard Berman, Ranking Minority Member Read the letter (432 KB PDF)
- Letter opposing use of Bayh-Dole march-in powers (324 KB PDF) (May 24, 2004)
- Letter regarding the Conference of the Parties of the Convention on Biological Diversity (365 KB PDF) (Feb. 5, 2004)
- BIO letter supporting the goals of H.R. 2391, the Cooperative Research and Technology Enhancement (CREATE) Act (87 KB PDF) (Jan. 21, 2004)
- BIO Letter to the Hon. Robert Zoellick, U.S. Trade Representative, in support of CAFTA (126 KB PDF) (Dec. 10, 2003)
- Letter to James E. Rogan on Unity of Invention (12/5/2003; 16.8 MB PDF)
- BIO Letter to the House Leadership supporting passage of H.R. 1561, the United States Patent and Trademark Fee Modernization Act of 2003 (Oct. 24, 2003)
- Letter to Office of Management and Budget on the PTO's strategic plan and their fee restructuring proposal (October 24, 2002)
- Letter to the Senate strongly supporting the Conference Agreement on the Department of Justice Authorization Act (HR 2215) and urging passage by the U.S. Senate (October 2, 2002)
- Letter to Sen. Ted Kennedy (11.2 MB PDF) expressing strong concerns regarding S. 812 (McCain/Schumer- Edwards/Collins) (July 15, 2002)
- Letter to Majority Leader Daschle, on Senator Brownback's patent amendment to S. 2600, the Terrorism Risk Insurance Act of 2002 (June 14, 2002)
- Letter to James Rogan (273 KB PDF), Under Secretary of Commerce for Intellectual Property and Director of the USPTO on Patent Harmonization (May 6, 2002)
- PTO response (1.2 MB PDF) to Carl Feldbaum on International Patent Harmonization Efforts
- Letter to the United States Senate (371 KB PDF) Supporting the Passage of Trade Promotion Authority Without Accompanying Amendments (May 6, 2002)
- Letter to Mr. Nicholas Godici (238 KB PDF), Acting Undersecretary of Commerce and Acting Director of the United States Patent and Trademark Office Regarding Patent Law Harmonization
- BIO letter (66.3 KB PDF) to the editor of the Washington Post clarifying the Bayh-Dole Act. (March 29, 2002)
- BIO letters outlining BIO opposition to HR 3967, The Genomic Research and Diagnostic Accessibility Act of 2002 (March 21, 2002):
- Letter to Carl B. Feldbaum, BIO President (64 KB PDF) from Samual W. Bodman, Deputy Secretary of Commerce regarding funding for the U.S. Patent and Trademark Office (Nov. 15, 2001)
- BIO letter (1.48 MB PDF) to J. Dennis Hastert (November 5, 2001)
- BIO letter (1.43 MB PDF) to US House of Representatives Energy and Commerce Chairman Tauzin outling BIO opposition to generic biologic and pediatric rule codification amendments on pediatric exclusity bill (October 1, 2001)
- BIO letter (1.39 MB PDF) to US House of Representatives Energy and Commerce Health Subcommittee Chairman Bilirakis outlining BIO opposition to generic biologic and pediatric rule codification amendments on pediatric exclusivity bill (October 1, 2001)
- BIO letter to Ontario Premier Michael Harris (September 26, 2001)
- Response to FTC Patent System Reform Recommendations (225 KB PDF) (Apr. 26, 2004)
- Statement Before the NIH Blue Ribbon Panel on Conflict of Interest Policies (171 KB PDF) (Apr. 16, 2004)
- NIH: Moving Research From the Bench to the Bedside July 10, 2003 Testimony Before the Energy and Commerce Health Subcommittee of the U.S. House of Representatives
- Bayh-Dole and Technology Transfer Apr. 11, 2002 Testimony Before the President's Council on Science and Technology
- Competition and Intellectual Property Law and Policy in the Knowledge E-Based Economy Feb. 26, 2002 Testimony Before the Federal Trade Commission and the Department of Justice
|
|
